Carotid body paraganglioma

Summary

Carotid body paraganglioma (MONDO:0021053) is a disease. A subtype of head and neck paraganglioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	carotid body paraganglioma
Mondo ID	MONDO:0021053
MeSH	D002345
NCIT	C2932
UMLS	C0007279
MedGen	2853
GARD	0010598
Anatomy (UBERON)	UBERON:0001629
Is cancer (heuristic)	no

Also known as: carotid body paraganglioma · carotid body tumour · paraganglioma of carotid body · tumour of carotid body · tumour of the carotid body

Disease family

This is a subtype of head and neck paraganglioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › autonomic nervous system disorder › autonomic nervous system neoplasm › paraganglioma › head and neck paraganglioma › carotid body paraganglioma

Related subtypes (3): jugulotympanic paraganglioma, tympanic paraganglioma, vagus nerve paraganglioma

Subtypes (3): malignant carotid body paraganglioma, benign carotid body paraganglioma, non-secreting chemodectoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.